insights_auto
Why is MYGN up 3,31%?
Dive Deeperchevron_right
MYGN:NASDAQ
Myriad Genetics Inc
USDÂ 4,37
arrow_upward
+3,31%(+0,14) 1D
30 Sep., 10:58:48 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MYGN...
Open
USDÂ 4,28
High
USDÂ 4,37
Low
USDÂ 4,22
Mkt. cap
417,99Â m
Avg. vol.
1,97Â m
Volume
125,01Â k
52-wk high
USDÂ 8,59
52-wk low
USDÂ 2,74
EPS
-USDÂ 1,20
Beta
1,68
Shares outstanding
95,65Â m
No. of employees
3Â k
Open
USDÂ 4,28
High
USDÂ 4,37
Low
USDÂ 4,22
Mkt. cap
417,99Â m
Avg. vol.
1,97Â m
Volume
125,01Â k
52-wk high
USDÂ 8,59
52-wk low
USDÂ 2,74
EPS
-USDÂ 1,20
Beta
1,68
Shares outstanding
95,65Â m
No. of employees
3Â k
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz | Paul J. Diaz
Employees2,7Â k
Founded1991
HeadquartersSalt Lake City, Utah, Verenigde State van Amerika
Sector-
Websitemyriad.com